Crossmark

The danger from within: alarmins in arthritis

Crossref DOI link: https://doi.org/10.1038/nrrheum.2016.162

Published Online: 2016-10-13

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nefla, Meriam

Holzinger, Dirk

Berenbaum, Francis

Jacques, Claire
License Information

Text and Data Mining valid from 2016-10-13
More Information

Article History

First Online: 13 October 2016

Competing interests

: D.H. declares that he has received speaker's fees from Novartis. M.N., F.B. and C.J. declare no competing interests.